HIV-TB Co-Infection among Clients Attending an Integrated Counselling & Testing Centre at Agra: Comparison with Studies in other Regions of India
DOI:
https://doi.org/10.12970/2309-0529.2018.06.01Keywords:
HIV-TB, co-infection, ICTC, Agra, India.Abstract
Settings: This prospective cross-sectional hospital based study was carried out in order to determine the prevalence of HIV-TB co-infection among patients attending an ICTC of this Institute at Agra. Methods: The socio-demographic characteristics and clinical profile of 5391 clients attending the ICTC were analyzed at the time of testing in the context of symptoms. All clients were screened for the presence of the signs and symptoms of TB disease. TB patients were referred to DOTS centre and HIV-positive patients were referred to ART centre, S.N.Medical College, Agra for further care and management. Results: In this study, HIV prevalence among clients was found to be 24% and HIV-TB co-infection was 12%. Major symptoms among these clients, at the time of testing, were weight loss, fever, cough and chronic diarrhea. Both HIV-positivity and HIV-TB co-infection were found to be higher among males, in the age group of 21-35 years, married, illiterate and working as daily laborers. Conclusion: Our study emphasizes the need for routine screening of clients for HIV and TB patients which, in turn, would guide the clinicians in deciding the appropriate treatment regimens in the management of HIV- TB co-infected patients.References
[1] WHO, World Health Organization: TB-HIV 2016. Factsheet Source 2016.
[2] Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021. https://doi.org/10.1001/archinte.163.9.1009
[3] Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G. (). Tuberculosis and HIV co-infection. PLoS Pathog 2012; 8: e1002464.
[4] Vermund S, Yamamoto N. Co-infection with human immunodeficiency virus and tuberculosis in Asia. Tuberculosis 2007; 87(S1): S18-S25.
[5] Trinh QM, Nguyen HL, Nguyen VN, Nguyen TVA, Sintchenko V, Marais BJ. Tuberculosis and HIV co-infection-focus on the Asia-Pacific region. Int J Inf Dis 2015; 32: 170-178. https://doi.org/10.1016/j.ijid.2014.11.023
[6] Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Ind J Med Res 2004; 120: 277-289.
[7] Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 1990; 335: 387-390. https://doi.org/10.1016/0140-6736(90)90216-R
[8] Lawn S, Churchyard G. Epidemiology of HIV associated tuberculosis. Curr Opin HIV/AIDS 2009; 4: 325-333. https://doi.org/10.1097/COH.0b013e32832c7d61
[9] Marfatia YS, Sharma A, Modi M. Overview of HIV/AIDS in India. Ind J Sex Transm Dis 2007; 28: 1-5. https://doi.org/10.4103/0253-7184.35702
[10] Sharma SK. Co-infection of human immunodeficiency virus (HIV) and tuberculosis: Indian perspective. Ind J Tuberc 2004; 51: 5-16.
[11] Collins KR, Quinones-Mateu ME, Toossi Z, Arts EJ. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev 2002; 4: 165-176.
[12] Getahun H, Gunneberg C, Granich R, Nunn P. HIV infectionassociated tuberculosis: the epidemiology and the response. Clin Infect Dis 2010; 50(S3): S201-S207. https://doi.org/10.1086/651492
[13] Guide to Supervision, Monitoring & Evaluation for HIV-TB Collaborative Activities. Central TB Division, Directorate General of Health services & Basic Services Division, National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India, New Delhi. January, 2016; 1-160.
[14] Revised National Tuberculosis Control Program. National Guideline For Partnership. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi 2014. www.tbcindia.nic.in
[15] WHO. Systematic Screening for Active Tuberculosis: Principles and Recommendations. Geneva: World Health Organization 2013; WHO/HTM/TB/2013.04.
[16] Index-TB Guidelines. Guidelines on extra-pulmonary TB for India. Initiative of Central TB Division, Ministry of Health and Family Welfare, Government of India
[17] Agarwal U, Kumar A, Behera D. Profile of HIV associated tuberculosis at a tertiary institute in setting of free antiretroviral therapy. J Assoc Physic Ind 2009; 57: 685-690.
[18] Bhattacharya MK, Naik TN, Ghosh M, Jana S, Dutta P. Pulmonary tuberculosis among HIV seropositives attending a counseling center in Kolkata. Ind J Pub Health 2011; 55: 329-331. https://doi.org/10.4103/0019-557X.92419
[19] Chandrasekaran V, Hegde MB, Kamath R, Pattanshetty S, Sharma V. HIV-TB co-infection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India. Lung India 2013; 30: 302-306. https://doi.org/10.4103/0970-2113.120605
[20] Chauhan T, Bhardwaj AK, Parashar A, Kanga AK. A study of an association between tuberculosis and HIV among ICTC attendees at a tertiary care hospital of Shimla, Himachal Pradesh, India. Int J Health Allied Sci 2012; 1: 142-146. https://doi.org/10.4103/2278-344X.105063
[21] Devi SB, Naorem S, Singh TJ, Singh KB, Prasad L. HIV and TB co-infection (a study from RIMS Hospital, Manipur). J Ind Acad Clin Med 2005; 6: 220-223.
[22] Ghiya R, Naik E, Casanas B, Izurieta R, Marfatia Y. Clinicoepidemiological profile of HIV/TB co-infected patients in Vadodara, Gujarat. Ind J Sex Transm Dis 2009; 30: 10-15. https://doi.org/10.4103/0253-7184.55472
[23] Jain S, Singh AK, Singh RP, Bajaj J, Damle AS. Surveillance of tuberculosis co-infection among HIV infected patients and their CD4+ cell count profile. As Pac J Trop Dis 2015; 5: 234. https://doi.org/10.1016/S2222-1808(14)60660-5
[24] Jaiswal RK, Srivastav S, Mahajan H. Socio demographic profile of TB-HIV co-infected patients in Bundelkhand Region, Uttar-Pradesh. Natl J Med Res 2012; 2: 149-151.
[25] Kamath R, Sharma V, Pattanshetty S, Mohandas B. Hegde MB, Chandrasekaran V. HIV-TB co-infection: Clinicoepidemiological determinants at an antiretroviral therapy center in Southern India. Lung India 2013; 30: 302-306. https://doi.org/10.4103/0970-2113.120605
[26] Naha K, Dasari S, Prabhu M. HIV-tuberculosis co-infection in an Indian scenario: The role of associated evidence of immune-suppression. As Pac J Trop Med 2013; 6: 320-324. https://doi.org/10.1016/S1995-7645(13)60064-4
[27] Padmapriyadarsini C, Narendran G, Swaminathan S. Diagnosis & treatment of tuberculosis in HIV co-infected patients. Ind J Med Res 2011; 134: 850-865. https://doi.org/10.4103/0971-5916.92630
[28] Patel AK, Thakrar SJ, Ghanchi FD. Clinical and laboratory profile of patients with TB/HIV co-infection: A case series of 50 patients. Lung India 2011; 28: 93-96. https://doi.org/10.4103/0970-2113.80316
[29] Rajasekaran S, Mahilmaran A, Annadurai S, Kumar S, Raja K. Manifestation of tuberculosis in patients with human immunodeficiency virus: A large Indian study. Ann Thorac Med 2007; 2: 58-60. https://doi.org/10.4103/1817-1737.32231
[30] Roshana A, Gopal R, Saleem M. Prevalence of pulmonary tuberculosis and HIV co- infection - a hospital based study at Puducherry. Ind J Microbiol Res 2015; 2: 126-127.
[31] Seth P. The situation of HIV/M.tuberculosis co-infection in India. Open Infect Dis J 2011; 5(suppl.1-M5): 51-59.
[32] Shrivastava SR, Shrivastava PS. HIV-tuberculosis interface: a comparison of collateral prevalence of HIV and tuberculosis in an urban health centre. Ann Trop Med Pub Health 2013; 6: 290-296. https://doi.org/10.4103/1755-6783.120986
[33] Singh RK. Prevalence of HIV/TB Co-infection among HIV Patients: Hospital Based Study from Northern Part of India. J Asso Physic Ind 2017; 65.
[34] Vajpayee M, Kanswal S, Seth P, Wig N, Pandey RM. Tuberculosis infections in HIV-infected Indian Patients. AIDS Patient Care STDS 2004; 18: 209-213. https://doi.org/10.1089/108729104323038883
[35] Vijay S, Swaminathan S, Vaidyanathan P, Thomas A, Chauhan LS, Kumar P, Chiddarwar S, Thomas B, Dewan PK. Feasibility of provider-initiated HIV testing and counselling of tuberculosis patients under the TB control programme in two districts of South India. PLoS One 2009; 4: e7899. https://doi.org/10.1371/journal.pone.0007899
[36] Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135. https://doi.org/10.1164/ajrccm.151.1.7812542
[37] Martin DJ, Sim JG, Sole GJ, Rymer L, Shalekoff S, van Niekerk AB. CD4+ lymphocyte count in African patients coinfected with HIV and tuberculosis. J Acquir Immune Defic Synd Hum Retrovirol 1995; 8: 386-391. https://doi.org/10.1097/00042560-199504000-00010
[38] Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010; 10: 455-463. https://doi.org/10.1016/S1473-3099(10)70093-1
[39] Shankar EM, Vignesh R, Ellegård R. Barathan M, Chong YK, Bador MK, Rukumani DV, Sabet NS. HIV-Mycobacterium tuberculosis co-infection: a danger-couple model’ of disease pathogenesis. Pathog Dis 2014; 70(2): 110-118. https://doi.org/10.1111/2049-632X.12108
[40] Shastri S, Naik B, Shet A, Rewari B, De Costa A. TB treatment outcomes among TB-HIV co-infections in Karnataka, India: How do these compare with non-HIV tuberculosis outcomes in the province? BMC Public Health 2013; 13: 838. https://doi.org/10.1186/1471-2458-13-838
